Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells

Biochemical Pharmacology

Volumn 67, Issue 2, 2004, Pages 315-324

  Takahashi, Keiko ^a   Loo, George ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Apoptosis; Cytochrome c; Mitochondria; Mitochondrial membrane potential; Mitochondrial permeability transition; Tocotrienols

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CYTOCHROME C; DNA FRAGMENT; GAMMA TOCOTRIENOL; LIPOCORTIN 5; MEMBRANE PHOSPHOLIPID; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CHROMATIN CONDENSATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME DEGRADATION; ENZYME RELEASE; HUMAN; HUMAN CELL; ISOMER; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 1642579535     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.07.015     Document Type: Article

References (42)

1. Packer L., Weber S.U., Rimbach G. Molecular aspects of α-tocotrienol antioxidant action and cell signaling. J. Nutr. 131:2001;369S-373S.
2. Kamal-Eldin A., Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotorienols. Lipids. 31:1996;671-701.
3. Theriault A., Chao J.-T., Wang Q., Gapor A., Adeli K. Tocotrienol: a review of its therapeutic potential. Clin. Biochem. 32:1999;309-319.
4. Nesaretnam K., Guthrie N., Chambers A.F., Carroll K.K. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids. 30:1995;1139-1143.
5. Guthrie N., Gapor A., Chambers A.F., Carroll K.K. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 127:1997;544S-548S.
6. Nesaretnam K., Stephen R., Dils R., Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids. 33:1998;461-469.
7. Yu W., Simmons-Menchaca M., Gapor A., Sanders B.G., Kline K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer. 33:1999;26-32.
8. Wilson M.R. Apoptosis: unmasking the executioner. Cell Death Differ. 5:1998;646-652.
9. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
10. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:1999;269-290.
11. King P., Goodbourn S. STAT1 is inactivated by a caspase. J. Biol. Chem. 273:1998;8699-8704.
12. Ravi R., Bedi A., Fuchs E.J., Bedi A. CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. Cancer Res. 58:1998;882-886.
13. Wang X., Zelenski N.G., Yang J., Sakai J., Brown M.S., Goldstein J.L. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J. 15:1996;1012-1020.
14. Duriez P.J., Shah G.M. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell Biol. 75:1997;337-349.
15. Fujita N., Tsuruo T. Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem. Biophys. Res. Commun. 246:1998;484-488.
16. Diederich L., Fotedar A., Fotedar R. Proteolytic cleavage of retinoblastoma protein upon DNA damage and fas-mediated apoptosis. Cell Biol. Toxicol. 14:1998;133-140.
17. Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene. 18:1999;1131-1138.
18. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature. 391:1998;43-50.
19. Bossy-Wetzel E., Green D.R. Assays for cytochrome c release from mitochondria during apoptosis. Methods Enzymol. 322:2000;235-242.
20. Zhang G., Gurtu V., Kain S.R., Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques. 23:1997;525-531.
21. Kuo S.M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110:1996;41-48.
22. 2+, common signals for apoptosis induced by gallic acid. Biochem. Pharmacol. 55:1998;1973-1981.
23. Sakagami H., Arakawa H., Maeda M., Satoh K., Kadofuku T., Fukuchi K., Gomi K. Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants. Anticancer Res. 21:2001;2633-2641.
24. Ueda S., Nakamura H., Masutani H., Sasada T., Takabayashi A., Yamaoka Y., Yodoi J. Baicalin induces apoptosis via mitochondrial pathway as prooxidant. Mol. Immunol. 38:2002;781-791.
25. Desagher S., Martinou J.-C. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:2000;369-377.
26. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341:1999;233-249.
27. Zoratti M., Szabó I. The mitochondrial permeability transition. Biochim. Biophys Acta. 1241:1995;139-176.
28. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
29. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
30. Smaili S.S., Hsu Y.T., Sanders K.M., Russell J.T., Youle R.J. Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential. Cell Death Differ. 8:2001;909-920.
31. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. U.S.A. 95:1998;4997-5002.
32. Hong C., Firestone G.L., Bjeldanes L.F. Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells. Biochem. Pharmacol. 63:2002;1085-1097.
33. Vergote D., Cren-Olive C., Chopin V., Toillon R.A., Rolando C., Hondermarck H., Le Bourhis X. (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Res. Treat. 76:2002;195-201.
34. Roucou X., Montessuit S., Antonsson B., Martinou J.C. Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem. J. 368:2002;915-921.
35. Li Y., Upadhyay S., Bhuiyan M., Sarkar F.H. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 18:1999;3166-3172.
36. Awad A.B., Roy R., Fink C.S. Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells. Oncol. Rep. 10:2003;497-500.
37. Zhang M., Guo R., Zhai Y., Yang D. LIGHT sensitizes IFNgamma-mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of anti-apoptosis Bcl-2 family members. Cancer Lett. 195:2003;201-210.
38. Herzig M.C., Liang H., Johnson A.E., Woynarowska B., Woynarowski J.M. Irofulven induces apoptosis in breast cancer cells regardless of caspase-3 status. Breast Cancer Res. Treat. 71:2002;133-143.
39. Bao J.J., Le X.F., Wang R.Y., Yuan J., Wang L., Atkinson E.N., LaPushin R., Andreeff M., Fang B., Yu Y., Bast R.C. Jr. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res. 62:2002;7264-7272.
40. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:1998;9357-9360.
41. Liang Y., Yan C., Schor N.F. Apoptosis in the absence of caspase 3. Oncogene. 20:2001;6570-6578.
42. Cande C., Cecconi F., Dessen P., Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J. Cell Sci. 115:2002;4727-4734.